Study of Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab (AMG 827) in Moderate to Severe Plaque Psoriasis Subjects
about
Study of Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab (AMG 827) in Moderate to Severe Plaque Psoriasis Subjects
description
clinical trial
@en
klinisch onderzoek
@nl
name
Study of Efficacy, Safety, and ...... vere Plaque Psoriasis Subjects
@en
Study of Efficacy, Safety, and ...... vere Plaque Psoriasis Subjects
@nl
type
label
Study of Efficacy, Safety, and ...... vere Plaque Psoriasis Subjects
@en
Study of Efficacy, Safety, and ...... vere Plaque Psoriasis Subjects
@nl
prefLabel
Study of Efficacy, Safety, and ...... vere Plaque Psoriasis Subjects
@en
Study of Efficacy, Safety, and ...... vere Plaque Psoriasis Subjects
@nl
P17
P1050
P1476
A Phase 3 Study to Evaluate th ...... re Plaque Psoriasis: AMAGINE-1
@en
P1813
AMAGINE-1
@en
P3098
NCT01708590
P580
2012-08-31T00:00:00Z
P582
2014-05-31T00:00:00Z